2022-2029 Global CAR-T Cell Immunotherapy Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

Code: RW00014695848
Maia Research
Jul-2022
Life Sciences
115 Pages

The CAR-T Cell Immunotherapy market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the CAR-T Cell Immunotherapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.

Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the CAR-T Cell Immunotherapy market.

Key players in the global CAR-T Cell Immunotherapy market covered in Chapter 2 and Chapter 6:
Genscript Biotech Corporation
CARsgen Therapeutics, Ltd.
Mustang Bio, Inc.
Aurora Biopharma Inc.
Gilead Sciences, Inc.
Pfizer, Inc.
Celgene Corporation
Sorrento Therapeutics Inc.
Novartis International AG

In Chapter 8 and Chapter 10.3, based on types, the CAR-T Cell Immunotherapy market from 2017 to 2029 is primarily split into:
CD19/CD22
BCMA (B-Cell Maturation Antigen)
Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

In Chapter 9 and Chapter 10.4, based on applications, the CAR-T Cell Immunotherapy market from 2017 to 2029 covers:
Diffuse Large B-Cell Lymphoma (DLBCL)
Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Multiple Myeloma (MM)
Follicular Lymphoma (FL)
Others

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions

Chapter 1 provides an overview of CAR-T Cell Immunotherapy market, containing global revenue and CAGR. The forecast and analysis of CAR-T Cell Immunotherapy market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 introduces the industrial chain of CAR-T Cell Immunotherapy. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.

Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in CAR-T Cell Immunotherapy industry, consumer behavior analysis.

Chapter 6 provides a full-scale analysis of major players in CAR-T Cell Immunotherapy industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 7 pays attention to the sales, revenue, price and gross margin of CAR-T Cell Immunotherapy in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 gives a worldwide view of CAR-T Cell Immunotherapy market. It includes sales, revenue, price, market share and the growth rate by type.

Chapter 9 focuses on the application of CAR-T Cell Immunotherapy, by analyzing the consumption and its growth rate of each application.

Chapter 10 prospects the whole CAR-T Cell Immunotherapy market, including the global sales and revenue forecast, regional forecast. It also foresees the CAR-T Cell Immunotherapy market by type and application.

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029

Table of Content

1 CAR-T Cell Immunotherapy Market Overview
1.1 Product Overview and Scope of CAR-T Cell Immunotherapy
1.2 CAR-T Cell Immunotherapy Segment by Type
1.2.1 Global CAR-T Cell Immunotherapy Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of CD19/CD22
1.2.3 The Market Profile of BCMA (B-Cell Maturation Antigen)
1.2.4 The Market Profile of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)
1.3 Global CAR-T Cell Immunotherapy Segment by Application
1.3.1 CAR-T Cell Immunotherapy Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Diffuse Large B-Cell Lymphoma (DLBCL)
1.3.3 The Market Profile of Acute Lymphoblastic Leukemia (ALL)
1.3.4 The Market Profile of Chronic Lymphocytic Leukemia (CLL)
1.3.5 The Market Profile of Multiple Myeloma (MM)
1.3.6 The Market Profile of Follicular Lymphoma (FL)
1.3.7 The Market Profile of Others
1.4 Global CAR-T Cell Immunotherapy Market, Region Wise (2017-2022)
1.4.1 Global CAR-T Cell Immunotherapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3 Europe CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.1 Germany CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.2 UK CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.3 France CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.4 Italy CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.5 Spain CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.6 Russia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.3.7 Poland CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.4 China CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.5 Japan CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.6 India CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.2 Singapore CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.3 Philippines CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.5 Thailand CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.8 Latin America CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.8.1 Brazil CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.8.2 Mexico CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.8.3 Colombia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.3 Turkey CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.4 Egypt CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.5 South Africa CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria CAR-T Cell Immunotherapy Market Status and Prospect (2017-2022)
1.5 Global Market Size of CAR-T Cell Immunotherapy (2017-2029)
1.5.1 Global CAR-T Cell Immunotherapy Revenue Status and Outlook (2017-2029)
1.5.2 Global CAR-T Cell Immunotherapy Sales Status and Outlook (2017-2029)

2 Global CAR-T Cell Immunotherapy Market Landscape by Player
2.1 Global CAR-T Cell Immunotherapy Sales and Share by Player (2017-2022)
2.2 Global CAR-T Cell Immunotherapy Revenue and Market Share by Player (2017-2022)
2.3 Global CAR-T Cell Immunotherapy Average Price by Player (2017-2022)
2.4 Global CAR-T Cell Immunotherapy Gross Margin by Player (2017-2022)
2.5 CAR-T Cell Immunotherapy Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 CAR-T Cell Immunotherapy Market Competitive Situation and Trends
2.6.1 CAR-T Cell Immunotherapy Market Concentration Rate
2.6.2 CAR-T Cell Immunotherapy Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion

3 CAR-T Cell Immunotherapy Upstream and Downstream Analysis
3.1 CAR-T Cell Immunotherapy Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19

4 CAR-T Cell Immunotherapy Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 CAR-T Cell Immunotherapy Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of CAR-T Cell Immunotherapy Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis

5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for CAR-T Cell Immunotherapy
5.3.2 Increased Demand in Emerging Markets
5.4 CAR-T Cell Immunotherapy Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on CAR-T Cell Immunotherapy Industry Development
5.5 Consumer Behavior Analysis

6 Players Profiles
6.1 Genscript Biotech Corporation
6.1.1 Genscript Biotech Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.1.3 Genscript Biotech Corporation CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.1.4 Genscript Biotech Corporation Business Overview
6.2 CARsgen Therapeutics, Ltd.
6.2.1 CARsgen Therapeutics, Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.2.3 CARsgen Therapeutics, Ltd. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.2.4 CARsgen Therapeutics, Ltd. Business Overview
6.3 Mustang Bio, Inc.
6.3.1 Mustang Bio, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.3.3 Mustang Bio, Inc. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.3.4 Mustang Bio, Inc. Business Overview
6.4 Aurora Biopharma Inc.
6.4.1 Aurora Biopharma Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.4.3 Aurora Biopharma Inc. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.4.4 Aurora Biopharma Inc. Business Overview
6.5 Gilead Sciences, Inc.
6.5.1 Gilead Sciences, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.5.3 Gilead Sciences, Inc. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.5.4 Gilead Sciences, Inc. Business Overview
6.6 Pfizer, Inc.
6.6.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.6.3 Pfizer, Inc. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.6.4 Pfizer, Inc. Business Overview
6.7 Celgene Corporation
6.7.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.7.3 Celgene Corporation CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.7.4 Celgene Corporation Business Overview
6.8 Sorrento Therapeutics Inc.
6.8.1 Sorrento Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.8.3 Sorrento Therapeutics Inc. CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.8.4 Sorrento Therapeutics Inc. Business Overview
6.9 Novartis International AG
6.9.1 Novartis International AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 CAR-T Cell Immunotherapy Product Profiles, Application and Specification
6.9.3 Novartis International AG CAR-T Cell Immunotherapy Market Performance (2017-2022)
6.9.4 Novartis International AG Business Overview

7 Global CAR-T Cell Immunotherapy Sales and Revenue Region Wise (2017-2022)
7.1 Global CAR-T Cell Immunotherapy Sales and Market Share, Region Wise (2017-2022)
7.2 Global CAR-T Cell Immunotherapy Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States CAR-T Cell Immunotherapy Market Under COVID-19
7.5 Europe CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe CAR-T Cell Immunotherapy Market Under COVID-19
7.6 China CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China CAR-T Cell Immunotherapy Market Under COVID-19
7.7 Japan CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan CAR-T Cell Immunotherapy Market Under COVID-19
7.8 India CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India CAR-T Cell Immunotherapy Market Under COVID-19
7.9 Southeast Asia CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia CAR-T Cell Immunotherapy Market Under COVID-19
7.10 Latin America CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America CAR-T Cell Immunotherapy Market Under COVID-19
7.11 Middle East and Africa CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa CAR-T Cell Immunotherapy Market Under COVID-19

8 Global CAR-T Cell Immunotherapy Sales, Revenue (Revenue), Price Trend by Type
8.1 Global CAR-T Cell Immunotherapy Sales and Market Share by Type (2017-2022)
8.2 Global CAR-T Cell Immunotherapy Revenue and Market Share by Type (2017-2022)
8.3 Global CAR-T Cell Immunotherapy Price by Type (2017-2022)
8.4 Global CAR-T Cell Immunotherapy Sales Growth Rate by Type (2017-2022)
8.4.1 Global CAR-T Cell Immunotherapy Sales Growth Rate of CD19/CD22 (2017-2022)
8.4.2 Global CAR-T Cell Immunotherapy Sales Growth Rate of BCMA (B-Cell Maturation Antigen) (2017-2022)
8.4.3 Global CAR-T Cell Immunotherapy Sales Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY) (2017-2022)

9 Global CAR-T Cell Immunotherapy Market Analysis by Application
9.1 Global CAR-T Cell Immunotherapy Consumption and Market Share by Application (2017-2022)
9.2 Global CAR-T Cell Immunotherapy Consumption Growth Rate by Application (2017-2022)
9.2.1 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Diffuse Large B-Cell Lymphoma (DLBCL) (2017-2022)
9.2.2 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
9.2.3 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Chronic Lymphocytic Leukemia (CLL) (2017-2022)
9.2.4 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Multiple Myeloma (MM) (2017-2022)
9.2.5 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Follicular Lymphoma (FL) (2017-2022)
9.2.6 Global CAR-T Cell Immunotherapy Consumption Growth Rate of Others (2017-2022)

10 Global CAR-T Cell Immunotherapy Market Forecast (2022-2029)
10.1 Global CAR-T Cell Immunotherapy Sales, Revenue Forecast (2022-2029)
10.1.1 Global CAR-T Cell Immunotherapy Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global CAR-T Cell Immunotherapy Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global CAR-T Cell Immunotherapy Price and Trend Forecast (2022-2029)
10.2 Global CAR-T Cell Immunotherapy Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.2 Europe CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.3 China CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.4 Japan CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.5 India CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa CAR-T Cell Immunotherapy Sales and Revenue Forecast (2022-2029)
10.3 Global CAR-T Cell Immunotherapy Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global CAR-T Cell Immunotherapy Consumption Forecast by Application (2022-2029)
10.5 CAR-T Cell Immunotherapy Market Forecast Under COVID-19

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Data Source

List of Tables and Figures

Figure CAR-T Cell Immunotherapy Product Picture
Table Global CAR-T Cell Immunotherapy Sales and CAGR (%) Comparison by Type
Table Profile of CD19/CD22
Table Profile of BCMA (B-Cell Maturation Antigen)
Table Profile of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)
Table CAR-T Cell Immunotherapy Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Diffuse Large B-Cell Lymphoma (DLBCL)
Table Profile of Acute Lymphoblastic Leukemia (ALL)
Table Profile of Chronic Lymphocytic Leukemia (CLL)
Table Profile of Multiple Myeloma (MM)
Table Profile of Follicular Lymphoma (FL)
Table Profile of Others
Figure Global CAR-T Cell Immunotherapy Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Europe CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Germany CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure UK CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure France CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Italy CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Spain CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Russia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Poland CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure China CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Japan CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure India CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Southeast Asia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Malaysia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Singapore CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Philippines CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Indonesia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Thailand CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Vietnam CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Latin America CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Brazil CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Mexico CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Colombia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Turkey CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Egypt CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure South Africa CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Nigeria CAR-T Cell Immunotherapy Revenue and Growth Rate (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Status and Outlook (2017-2029)
Table Global CAR-T Cell Immunotherapy Sales by Player (2017-2022)
Table Global CAR-T Cell Immunotherapy Sales Share by Player (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Share by Player in 2021
Table CAR-T Cell Immunotherapy Revenue by Player (2017-2022)
Table CAR-T Cell Immunotherapy Revenue Market Share by Player (2017-2022)
Table CAR-T Cell Immunotherapy Price by Player (2017-2022)
Table CAR-T Cell Immunotherapy Gross Margin by Player (2017-2022)
Table CAR-T Cell Immunotherapy Manufacturing Base Distribution and Sales Area by Player
Table CAR-T Cell Immunotherapy Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure CAR-T Cell Immunotherapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of CAR-T Cell Immunotherapy
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on CAR-T Cell Immunotherapy Industry Development
Table Genscript Biotech Corporation Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Genscript Biotech Corporation CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Genscript Biotech Corporation Revenue and Growth Rate
Figure Genscript Biotech Corporation Revenue Market Share 2017-2022
Table CARsgen Therapeutics, Ltd. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table CARsgen Therapeutics, Ltd. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure CARsgen Therapeutics, Ltd. Revenue and Growth Rate
Figure CARsgen Therapeutics, Ltd. Revenue Market Share 2017-2022
Table Mustang Bio, Inc. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Mustang Bio, Inc. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Mustang Bio, Inc. Revenue and Growth Rate
Figure Mustang Bio, Inc. Revenue Market Share 2017-2022
Table Aurora Biopharma Inc. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Aurora Biopharma Inc. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Aurora Biopharma Inc. Revenue and Growth Rate
Figure Aurora Biopharma Inc. Revenue Market Share 2017-2022
Table Gilead Sciences, Inc. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Gilead Sciences, Inc. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2017-2022
Table Pfizer, Inc. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Pfizer, Inc. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Revenue and Growth Rate
Figure Pfizer, Inc. Revenue Market Share 2017-2022
Table Celgene Corporation Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Celgene Corporation CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Celgene Corporation Revenue and Growth Rate
Figure Celgene Corporation Revenue Market Share 2017-2022
Table Sorrento Therapeutics Inc. Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Sorrento Therapeutics Inc. CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Sorrento Therapeutics Inc. Revenue and Growth Rate
Figure Sorrento Therapeutics Inc. Revenue Market Share 2017-2022
Table Novartis International AG Profile
Table CAR-T Cell Immunotherapy Product Profiles, Application and Specification
Table Novartis International AG CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novartis International AG Revenue and Growth Rate
Figure Novartis International AG Revenue Market Share 2017-2022
Table Global CAR-T Cell Immunotherapy Sales, Region Wise (2017-2022)
Table Global CAR-T Cell Immunotherapy Sales Market Share, Region Wise (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Market Share, Region Wise (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Market Share, Region Wise in 2021
Table Global CAR-T Cell Immunotherapy Revenue, Region Wise (2017-2022)
Table Global CAR-T Cell Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global CAR-T Cell Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global CAR-T Cell Immunotherapy Revenue Market Share, Region Wise in 2021
Table Global CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table China CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table India CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa CAR-T Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global CAR-T Cell Immunotherapy Sales by Type (2017-2022)
Table Global CAR-T Cell Immunotherapy Sales Market Share by Type (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Market Share by Type in 2022
Table Global CAR-T Cell Immunotherapy Revenue by Type (2017-2022)
Table Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2017-2022)
Figure Global CAR-T Cell Immunotherapy Revenue Market Share by Type in 2022
Table CAR-T Cell Immunotherapy Price by Type (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Growth Rate of CD19/CD22 (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Growth Rate of BCMA (B-Cell Maturation Antigen) (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales Growth Rate of Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption by Application (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption Market Share by Application (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Diffuse Large B-Cell Lymphoma (DLBCL) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Chronic Lymphocytic Leukemia (CLL) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Multiple Myeloma (MM) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Follicular Lymphoma (FL) (2017-2022)
Table Global CAR-T Cell Immunotherapy Consumption of Others (2017-2022)
Figure Global CAR-T Cell Immunotherapy Sales and Growth Rate Forecast (2022-2029)
Figure Global CAR-T Cell Immunotherapy Revenue and Growth Rate Forecast (2022-2029)
Figure Global CAR-T Cell Immunotherapy Price and Trend Forecast (2022-2029)
Figure USA CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure India CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa CAR-T Cell Immunotherapy Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa CAR-T Cell Immunotherapy Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Table Global CAR-T Cell Immunotherapy Market Sales Forecast, by Type
Table Global CAR-T Cell Immunotherapy Sales Volume Market Share Forecast, by Type
Table Global CAR-T Cell Immunotherapy Market Revenue Forecast, by Type
Table Global CAR-T Cell Immunotherapy Revenue Market Share Forecast, by Type
Table Global CAR-T Cell Immunotherapy Price Forecast, by Type
Table Global CAR-T Cell Immunotherapy Market Consumption Forecast, by Application
Table Global CAR-T Cell Immunotherapy Consumption Volume Market Share Forecast, by Application
Table Global CAR-T Cell Immunotherapy Market Revenue Forecast, by Application
Table Global CAR-T Cell Immunotherapy Revenue Market Share Forecast, by Application
Table Global CAR-T Cell Immunotherapy Price Forecast, by Application

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE